Methotrexate Chemo Or Spices for Reducing Risk of Heart Disease

Majid Ali, M.D.

Methotrexate – A Chemotherapy Drug to Reduce Risk of Heart Disease!

Taking a toxic chemotherapy drug to reduce the risk of heart disease? You frown with disbelief. My answer: Yes, you read the title of this article right. Methotrexate indeed is a chemotherapy drug. And yes it is being used to reduce the risk of cardiovascular disease. If my words stretch you credulity, please read a direct quote from The New York Times of August 28, 2017, page A13.


Below is a direct quote from The New York Times of August 28, 2017.

“Another, older and much cheaper anti-inflammatory drug, methotrexate, is also being studied to see if it can reduce cardiovascular risk, and Dr. Mosca said that if it works, it might be a more practical treatment. Dr. Ridker is also overseeing that study, which is being paid for by the federal government.” (The New York Times. August 28, 2017
Here is something else to know. Methotrexate is a liver toxin and the relevant standard-of-care requires that periodic liver biopsy be done to detect liver damage. The standard mandates that methotrexate be discontinued if the liver biopsy reveals liver injury.

You might read another excerpt from the Times account: “The drug that was studied, canakinumab, is already marketed under the brand name Ilaris, but was approved to treat a type of juvenile rheumatoid arthritis and other rare disorders, not heart disease. It costs $ 200,000.00 foe one year treatment,


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: